Clinical trial

NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

NCT04335669

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2019-12-20

PhasePHASE3

Study timeline

Study start (actual)2019-12-20Date precision: day

Registry last updated2025-09-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Triple Negative Breast Neoplasmsunresolved

Interventions

epirubicin, cyclophosphamide, paclitaxel, carboplatin, pembrolizumabDRUG

epirubicin, cyclophosphamide, capecitabine, paclitaxel, carboplatin, pembrolizumabDRUG

Sponsors & collaborators

Lund University Hospitallead sponsor

Swedish Breast Cancer Groupcollaborator

Danish Breast Cancer Cooperative Groupcollaborator

Mapped research locations

StockholmSweden2 CopenhagenDenmark1 GothenburgSweden1 UppsalaSweden1 MalmöSweden1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04335669 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.